View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsProbiotec 과거 순이익 실적과거 기준 점검 2/6Probiotec은 연평균 24.6%의 비율로 수입이 증가해 온 반면, Pharmaceuticals 산업은 수입이 5.8% 증가했습니다. 매출은 연평균 24.6%의 비율로 증가했습니다. Probiotec의 자기자본이익률은 9.8%이고 순이익률은 3.9%입니다.핵심 정보24.59%순이익 성장률19.47%주당순이익(EPS) 성장률Pharmaceuticals 산업 성장률31.22%매출 성장률24.64%자기자본이익률9.83%순이익률3.93%최근 순이익 업데이트31 Dec 2023최근 과거 실적 업데이트Reported Earnings • Aug 26Full year 2023 earnings released: EPS: AU$0.14 (vs AU$0.17 in FY 2022)Full year 2023 results: EPS: AU$0.14 (down from AU$0.17 in FY 2022). Revenue: AU$214.0m (up 17% from FY 2022). Net income: AU$11.0m (down 20% from FY 2022). Profit margin: 5.1% (down from 7.5% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.Reported Earnings • Feb 25First half 2023 earnings released: EPS: AU$0.067 (vs AU$0.056 in 1H 2022)First half 2023 results: EPS: AU$0.067 (up from AU$0.056 in 1H 2022). Revenue: AU$106.8m (up 25% from 1H 2022). Net income: AU$5.46m (up 23% from 1H 2022). Profit margin: 5.1% (down from 5.2% in 1H 2022). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Reported Earnings • Aug 25Full year 2022 earnings released: EPS: AU$0.17 (vs AU$0.066 in FY 2021)Full year 2022 results: EPS: AU$0.17 (up from AU$0.066 in FY 2021). Revenue: AU$182.3m (up 51% from FY 2021). Net income: AU$13.7m (up 170% from FY 2021). Profit margin: 7.5% (up from 4.2% in FY 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 7.6%, compared to a 717% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.Reported Earnings • Mar 01First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0.056 (up from AU$0.017 in 1H 2021). Revenue: AU$85.2m (up 100% from 1H 2021). Net income: AU$4.44m (up 259% from 1H 2021). Profit margin: 5.2% (up from 2.9% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 296% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 13% per year.Reported Earnings • Mar 01First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0.056 (up from AU$0.017 in 1H 2021). Revenue: AU$85.2m (up 100% from 1H 2021). Net income: AU$4.44m (up 259% from 1H 2021). Profit margin: 5.2% (up from 2.9% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 296% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 13% per year.모든 업데이트 보기Recent updates공고 • Jun 18PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited (ASX:PBP).PYFA Australia Pty Ltd entered into a binding scheme implementation deed to acquire remaining 89.67% stake in Probiotec Limited (ASX:PBP) for approximately AUD 240 million on December 21, 2023. The transaction will be financed from combination of debt and direct or indirect equity contributions. The transaction is subject to regulatory approvals, approval by shareholders of PT Pyridam Farma Tbk and Probiotec Limited and court approvals. As of May 10, 2024, The deal has been approved by Foreign Investment Review Board. The transaction has been approved by the Federal Court of Australia. The transaction is expected to close on June 18, 2024. Canterbury Partners Pty Ltd acted as financial and Arnold Bloch Leibler and Soewito Suhardiman Eddymurthy Kardono acted as legal advisors to Probiotec Limited. Grant Samuel Group Limited and PT Mandiri Sekuritas acted as financial and Ashurst Australia and Armand, Yapsunto, Muharamsyah & Partners acted as legal advisor to PYFA Australia Pty Ltd. Boardroom Pty Limited acted as registrar to Probiotec Limited. Grant Thornton Corporate Finance Pty Ltd, Investment Banking Arm acted as financial advisor to Probiotec. PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited (ASX:PBP) on June 18, 2024. Trading in Probiotec shares on ASX was suspended at the close of trading on June 5, 2024. Probiotec has applied for its removal from the official list of ASX with effect from the close of trading as on June 19, 2024. Jared Stringer and Andrew Phillips have been appointed as new Directors of Probiotec.Declared Dividend • Mar 01First half dividend of AU$0.035 announcedShareholders will receive a dividend of AU$0.035. Ex-date: 4th March 2024 Payment date: 15th March 2024 Dividend yield will be 2.5%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (61% earnings payout ratio) but not covered by cash flows (110% cash payout ratio). The dividend has increased by an average of 20% per year over the past 8 years. However, payments have been volatile during that time. Earnings per share has grown by 12% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.Recent Insider Transactions • Jan 17CEO, MD & Executive Director recently sold AU$743k worth of stockOn the 12th of January, Wesley Stringer sold around 260k shares on-market at roughly AU$2.86 per share. This transaction amounted to 5.0% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Wesley's only on-market trade for the last 12 months.Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 20%After last week's 20% share price gain to AU$2.89, the stock trades at a trailing P/E ratio of 21.5x. Average forward P/E is 18x in the Pharmaceuticals industry in Australia. Total returns to shareholders of 35% over the past three years.New Risk • Dec 08New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.9% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (5.1% net profit margin).공고 • Oct 13Probiotec Limited, Annual General Meeting, Nov 15, 2023Probiotec Limited, Annual General Meeting, Nov 15, 2023, at 11:00 E. Australia Standard Time. Location: Morgans, Level 25, 367 Collins Street, Melbourne VIC 3000 Melbourne Australia Agenda: To receive and consider the Financial Report, Directors' Report and Auditor's Report for the year ended 30 June 2023; to consider and, if thought fit, pass the following non-binding ordinary resolution: That the Remuneration Report for the year ended 30 June 2023 be adopted; and to consider other matters.New Risk • Aug 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.1% Last year net profit margin: 7.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company.Reported Earnings • Aug 26Full year 2023 earnings released: EPS: AU$0.14 (vs AU$0.17 in FY 2022)Full year 2023 results: EPS: AU$0.14 (down from AU$0.17 in FY 2022). Revenue: AU$214.0m (up 17% from FY 2022). Net income: AU$11.0m (down 20% from FY 2022). Profit margin: 5.1% (down from 7.5% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.공고 • Aug 25Probiotec Limited Declares Fully Franked Final Dividend for the Period of Six Months Ended June 30, 2023 , Payable on 8 September 2023Probiotec Limited declared a Fully Franked final dividend for the period of six months ended June 30, 2023 of 3.5 cents per ordinary share, fully franked, and to be paid on 8 September 2023. The dividend will be payable to shareholders of record on 1 September 2023. The October 31, 2023.Reported Earnings • Feb 25First half 2023 earnings released: EPS: AU$0.067 (vs AU$0.056 in 1H 2022)First half 2023 results: EPS: AU$0.067 (up from AU$0.056 in 1H 2022). Revenue: AU$106.8m (up 25% from 1H 2022). Net income: AU$5.46m (up 23% from 1H 2022). Profit margin: 5.1% (down from 5.2% in 1H 2022). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.Recent Insider Transactions • Oct 19Chairman of the Board recently bought AU$97k worth of stockOn the 14th of October, Jonathan Wenig bought around 45k shares on-market at roughly AU$2.16 per share. This transaction amounted to 64% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Jonathan's only on-market trade for the last 12 months.Upcoming Dividend • Aug 31Upcoming dividend of AU$0.035 per shareEligible shareholders must have bought the stock before 07 September 2022. Payment date: 15 September 2022. Payout ratio is a comfortable 32% and this is well supported by cash flows. Trailing yield: 2.4%. Lower than top quartile of Australian dividend payers (6.6%). In line with average of industry peers (2.5%).Reported Earnings • Aug 25Full year 2022 earnings released: EPS: AU$0.17 (vs AU$0.066 in FY 2021)Full year 2022 results: EPS: AU$0.17 (up from AU$0.066 in FY 2021). Revenue: AU$182.3m (up 51% from FY 2021). Net income: AU$13.7m (up 170% from FY 2021). Profit margin: 7.5% (up from 4.2% in FY 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 7.6%, compared to a 717% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.Board Change • Apr 28Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Simon Gray was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Recent Insider Transactions • Mar 09Independent Non-Executive Director recently bought AU$54k worth of stockOn the 7th of March, Simon Gray bought around 25k shares on-market at roughly AU$2.17 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.Reported Earnings • Mar 01First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0.056 (up from AU$0.017 in 1H 2021). Revenue: AU$85.2m (up 100% from 1H 2021). Net income: AU$4.44m (up 259% from 1H 2021). Profit margin: 5.2% (up from 2.9% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 296% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 13% per year.Reported Earnings • Mar 01First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0.056 (up from AU$0.017 in 1H 2021). Revenue: AU$85.2m (up 100% from 1H 2021). Net income: AU$4.44m (up 259% from 1H 2021). Profit margin: 5.2% (up from 2.9% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 296% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 13% per year.Executive Departure • Nov 29Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 29Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 29Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.매출 및 비용 세부 내역Probiotec가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이CHIA:PBP 매출, 비용 및 순이익 (AUD Millions)날짜매출순이익일반관리비연구개발비31 Dec 23221947030 Sep 232181045030 Jun 232141144031 Mar 232091343031 Dec 222041541030 Sep 221931440030 Jun 221821438031 Dec 21163834030 Sep 21142731030 Jun 21121528031 Dec 20106624030 Sep 20106622030 Jun 20107621031 Mar 2096519031 Dec 1984418030 Sep 1979417030 Jun 1973417031 Mar 1973418031 Dec 1872419030 Sep 1869319030 Jun 1866319031 Dec 1760218030 Sep 1761318030 Jun 1761318031 Dec 1663319030 Sep 1664320030 Jun 1666220031 Dec 1564122030 Sep 1564122030 Jun 1563023031 Dec 1465-124030 Sep 1467024030 Jun 1468125031 Dec 1365225030 Sep 1366226030 Jun 13671270양질의 수익: PBP는 고품질 수익을 보유하고 있습니다.이익 마진 증가: PBP의 현재 순 이익률 (3.9%)은 지난해 (7.2%)보다 낮습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: PBP의 수익은 지난 5년 동안 연평균 24.6%로 크게 증가했습니다.성장 가속화: PBP은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: PBP은 지난 1년 동안 수익이 감소(-41%)하여 Pharmaceuticals 업계 평균(-17.4%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: PBP의 자본 수익률(9.8%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2024/06/18 12:54종가2024/06/18 00:00수익2023/12/31연간 수익2023/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Probiotec Limited는 6명의 분석가가 다루고 있습니다. 이 중 1명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Andrew TangMorgans Financial LimitedJames FiliusMorgans Financial LimitedRichard IversOrd Minnett Limited3명의 분석가 더 보기
Reported Earnings • Aug 26Full year 2023 earnings released: EPS: AU$0.14 (vs AU$0.17 in FY 2022)Full year 2023 results: EPS: AU$0.14 (down from AU$0.17 in FY 2022). Revenue: AU$214.0m (up 17% from FY 2022). Net income: AU$11.0m (down 20% from FY 2022). Profit margin: 5.1% (down from 7.5% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Feb 25First half 2023 earnings released: EPS: AU$0.067 (vs AU$0.056 in 1H 2022)First half 2023 results: EPS: AU$0.067 (up from AU$0.056 in 1H 2022). Revenue: AU$106.8m (up 25% from 1H 2022). Net income: AU$5.46m (up 23% from 1H 2022). Profit margin: 5.1% (down from 5.2% in 1H 2022). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Aug 25Full year 2022 earnings released: EPS: AU$0.17 (vs AU$0.066 in FY 2021)Full year 2022 results: EPS: AU$0.17 (up from AU$0.066 in FY 2021). Revenue: AU$182.3m (up 51% from FY 2021). Net income: AU$13.7m (up 170% from FY 2021). Profit margin: 7.5% (up from 4.2% in FY 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 7.6%, compared to a 717% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Mar 01First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0.056 (up from AU$0.017 in 1H 2021). Revenue: AU$85.2m (up 100% from 1H 2021). Net income: AU$4.44m (up 259% from 1H 2021). Profit margin: 5.2% (up from 2.9% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 296% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 13% per year.
Reported Earnings • Mar 01First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0.056 (up from AU$0.017 in 1H 2021). Revenue: AU$85.2m (up 100% from 1H 2021). Net income: AU$4.44m (up 259% from 1H 2021). Profit margin: 5.2% (up from 2.9% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 296% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 13% per year.
공고 • Jun 18PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited (ASX:PBP).PYFA Australia Pty Ltd entered into a binding scheme implementation deed to acquire remaining 89.67% stake in Probiotec Limited (ASX:PBP) for approximately AUD 240 million on December 21, 2023. The transaction will be financed from combination of debt and direct or indirect equity contributions. The transaction is subject to regulatory approvals, approval by shareholders of PT Pyridam Farma Tbk and Probiotec Limited and court approvals. As of May 10, 2024, The deal has been approved by Foreign Investment Review Board. The transaction has been approved by the Federal Court of Australia. The transaction is expected to close on June 18, 2024. Canterbury Partners Pty Ltd acted as financial and Arnold Bloch Leibler and Soewito Suhardiman Eddymurthy Kardono acted as legal advisors to Probiotec Limited. Grant Samuel Group Limited and PT Mandiri Sekuritas acted as financial and Ashurst Australia and Armand, Yapsunto, Muharamsyah & Partners acted as legal advisor to PYFA Australia Pty Ltd. Boardroom Pty Limited acted as registrar to Probiotec Limited. Grant Thornton Corporate Finance Pty Ltd, Investment Banking Arm acted as financial advisor to Probiotec. PYFA Australia Pty Ltd completed the acquisition of remaining 89.67% stake in Probiotec Limited (ASX:PBP) on June 18, 2024. Trading in Probiotec shares on ASX was suspended at the close of trading on June 5, 2024. Probiotec has applied for its removal from the official list of ASX with effect from the close of trading as on June 19, 2024. Jared Stringer and Andrew Phillips have been appointed as new Directors of Probiotec.
Declared Dividend • Mar 01First half dividend of AU$0.035 announcedShareholders will receive a dividend of AU$0.035. Ex-date: 4th March 2024 Payment date: 15th March 2024 Dividend yield will be 2.5%, which is about the same as the industry average. Sustainability & Growth Dividend is covered by earnings (61% earnings payout ratio) but not covered by cash flows (110% cash payout ratio). The dividend has increased by an average of 20% per year over the past 8 years. However, payments have been volatile during that time. Earnings per share has grown by 12% over the last 5 years. Unless this trend reverses, it should provide support to the dividend and adequate earnings cover.
Recent Insider Transactions • Jan 17CEO, MD & Executive Director recently sold AU$743k worth of stockOn the 12th of January, Wesley Stringer sold around 260k shares on-market at roughly AU$2.86 per share. This transaction amounted to 5.0% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Wesley's only on-market trade for the last 12 months.
Valuation Update With 7 Day Price Move • Dec 22Investor sentiment improves as stock rises 20%After last week's 20% share price gain to AU$2.89, the stock trades at a trailing P/E ratio of 21.5x. Average forward P/E is 18x in the Pharmaceuticals industry in Australia. Total returns to shareholders of 35% over the past three years.
New Risk • Dec 08New minor risk - Dividend sustainabilityThe company has an unstable dividend paying track record. The dividend has had an annual drop of over 20% in the past. Dividend yield: 2.9% This is considered a minor risk. If the company has cut or reduced its dividend in the past, it may be a sign that the underlying business is too cyclical to consistently maintain or grow the dividend over the long-term. It may also indicate the company prioritizes other outcomes instead of maintaining the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Profit margins are more than 30% lower than last year (5.1% net profit margin).
공고 • Oct 13Probiotec Limited, Annual General Meeting, Nov 15, 2023Probiotec Limited, Annual General Meeting, Nov 15, 2023, at 11:00 E. Australia Standard Time. Location: Morgans, Level 25, 367 Collins Street, Melbourne VIC 3000 Melbourne Australia Agenda: To receive and consider the Financial Report, Directors' Report and Auditor's Report for the year ended 30 June 2023; to consider and, if thought fit, pass the following non-binding ordinary resolution: That the Remuneration Report for the year ended 30 June 2023 be adopted; and to consider other matters.
New Risk • Aug 26New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 5.1% Last year net profit margin: 7.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. This is currently the only risk that has been identified for the company.
Reported Earnings • Aug 26Full year 2023 earnings released: EPS: AU$0.14 (vs AU$0.17 in FY 2022)Full year 2023 results: EPS: AU$0.14 (down from AU$0.17 in FY 2022). Revenue: AU$214.0m (up 17% from FY 2022). Net income: AU$11.0m (down 20% from FY 2022). Profit margin: 5.1% (down from 7.5% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth.
공고 • Aug 25Probiotec Limited Declares Fully Franked Final Dividend for the Period of Six Months Ended June 30, 2023 , Payable on 8 September 2023Probiotec Limited declared a Fully Franked final dividend for the period of six months ended June 30, 2023 of 3.5 cents per ordinary share, fully franked, and to be paid on 8 September 2023. The dividend will be payable to shareholders of record on 1 September 2023. The October 31, 2023.
Reported Earnings • Feb 25First half 2023 earnings released: EPS: AU$0.067 (vs AU$0.056 in 1H 2022)First half 2023 results: EPS: AU$0.067 (up from AU$0.056 in 1H 2022). Revenue: AU$106.8m (up 25% from 1H 2022). Net income: AU$5.46m (up 23% from 1H 2022). Profit margin: 5.1% (down from 5.2% in 1H 2022). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth.
Recent Insider Transactions • Oct 19Chairman of the Board recently bought AU$97k worth of stockOn the 14th of October, Jonathan Wenig bought around 45k shares on-market at roughly AU$2.16 per share. This transaction amounted to 64% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Jonathan's only on-market trade for the last 12 months.
Upcoming Dividend • Aug 31Upcoming dividend of AU$0.035 per shareEligible shareholders must have bought the stock before 07 September 2022. Payment date: 15 September 2022. Payout ratio is a comfortable 32% and this is well supported by cash flows. Trailing yield: 2.4%. Lower than top quartile of Australian dividend payers (6.6%). In line with average of industry peers (2.5%).
Reported Earnings • Aug 25Full year 2022 earnings released: EPS: AU$0.17 (vs AU$0.066 in FY 2021)Full year 2022 results: EPS: AU$0.17 (up from AU$0.066 in FY 2021). Revenue: AU$182.3m (up 51% from FY 2021). Net income: AU$13.7m (up 170% from FY 2021). Profit margin: 7.5% (up from 4.2% in FY 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 7.6%, compared to a 717% growth forecast for the Pharmaceuticals industry in Australia. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth.
Board Change • Apr 28Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Director Simon Gray was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Recent Insider Transactions • Mar 09Independent Non-Executive Director recently bought AU$54k worth of stockOn the 7th of March, Simon Gray bought around 25k shares on-market at roughly AU$2.17 per share. This was the largest purchase by an insider in the last 3 months. This was the only on-market transaction from insiders over the last 12 months.
Reported Earnings • Mar 01First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0.056 (up from AU$0.017 in 1H 2021). Revenue: AU$85.2m (up 100% from 1H 2021). Net income: AU$4.44m (up 259% from 1H 2021). Profit margin: 5.2% (up from 2.9% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 296% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 13% per year.
Reported Earnings • Mar 01First half 2022 earnings: Revenues and EPS in line with analyst expectationsFirst half 2022 results: EPS: AU$0.056 (up from AU$0.017 in 1H 2021). Revenue: AU$85.2m (up 100% from 1H 2021). Net income: AU$4.44m (up 259% from 1H 2021). Profit margin: 5.2% (up from 2.9% in 1H 2021). The increase in margin was driven by higher revenue. Revenue was in line with analyst estimates. Over the next year, revenue is forecast to grow 12%, compared to a 296% growth forecast for the industry in Australia. Over the last 3 years on average, earnings per share has increased by 15% per year whereas the company’s share price has increased by 13% per year.
Executive Departure • Nov 29Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 29Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 29Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 28Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 27Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 26Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.
Executive Departure • Nov 25Independent Non-Executive Director Gregory Lan has left the companyOn the 24th of November, Gregory Lan's tenure as Independent Non-Executive Director ended after 4.8 years in the role. As of September 2021, Gregory still personally held 113.74k shares (AU$251k worth at the time). A total of 2 executives have left over the last 12 months.